Funder: Novo Nordisk
Due Dates: October 8, 2025 (2:00pm Copenhagen time) | Call opens April 28, 2025
Funding Amounts: DKK 40–75 million (approx. EUR 5.4–10 million) per grant over 6 years; up to DKK 150 million total for this theme
Summary: Funds ambitious, collaborative research to advance understanding and solutions for human invasive fungal diseases, including diagnostics and therapeutics.
Key Information: Consortium must include at least one Danish institution; main applicant must be based in Europe (EU, Schengen, UK).